Literature DB >> 24275270

Mycoplasma genitalium: An emergent sexually transmitted disease?

Lisa E Manhart1.   

Abstract

This article summarizes the epidemiologic evidence linking Mycoplasma genitalium to sexually transmitted disease syndromes, including male urethritis, and female cervicitis, pelvic inflammatory disease, infertility, and adverse birth outcomes. It discusses the relationship of this bacterium to human immunodeficiency virus infection and reviews the available literature on the efficacy of standard antimicrobial therapies against M genitalium.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervicitis; Mycoplasma genitalium; NGU; Pelvic inflammatory disease; STD; STI; Urethritis

Mesh：

Substances：

Year:  2013        PMID： 24275270     DOI： 10.1016/j.idc.2013.08.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  13 in total

1.  Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens.

Authors:  Patricia M Dehon; Chris L McGowin
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

2.  Diagnostic and resistance testing for Mycoplasma genitalium: what will it take?

Authors:  Lisa E Manhart
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

3.  Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinic.

Authors:  Rania Abdelmonem Khattab; Maha Mohssen Abdelfattah
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 4.  Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.

Authors:  Charlotte A Gaydos
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

5.  Histological Evidence of Chronic Mycoplasma genitalium-Induced Cervicitis in HIV-Infected Women: A Retrospective Cohort Study.

Authors:  Patricia M Dehon; Michael E Hagensee; Kimberly J Sutton; Hope E Oddo; Nia Nelson; Chris L McGowin
Journal:  J Infect Dis       Date:  2016-01-17       Impact factor: 5.226

Review 6.  Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations.

Authors:  Deborah L Couldwell; David A Lewis
Journal:  Infect Drug Resist       Date:  2015-05-26       Impact factor: 4.003

7.  Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance.

Authors:  Thomas Trevis; Marianne Gossé; Nicola Santarossa; Sepehr Tabrizi; Darren Russell; William John McBride
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

Review 8.  Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?

Authors:  Samsiya Ona; Rose L Molina; Khady Diouf
Journal:  Infect Dis Obstet Gynecol       Date:  2016-04-24

9.  Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.

Authors:  Danyang Liu; Yang Hu; Ying Guo; Zhu Zhu; Bingzheng Lu; Xuelan Wang; Yijun Huang
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

10.  Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials.

Authors:  Ricardo F Savaris; Daniele G Fuhrich; Rui V Duarte; Sebastian Franik; Jonathan D C Ross
Journal:  Sex Transm Infect       Date:  2018-10-19       Impact factor: 3.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.